Rephonic
Artwork for Pharmaceutical Executive

Pharmaceutical Executive

Pharmaceutical Executive Podcast
FDA
Eli Lilly
Novo Nordisk
Artificial Intelligence
Astrazeneca
Bristol Myers Squibb
Moderna
Pfizer
Novartis
Abbvie
GSK
Biontech
Sanofi
Insilico Medicine
Shionogi
Pharmaceutical Industry
United States
Most Favored Nation Pricing
Merck
Clinical Trials

The Pharm Exec Podcast goes beyond the pages of the Pharmaceutical Executive print magazine and PharmExec.com to bring the latest commercial insights to the C-suite through in-depth interviews. Podcast episodes examine current trends, key conferences, and critical topics in the industry.

PublishesDailyEpisodes477Founded9 years ago
Number of ListenersCategories
Life SciencesScience

Listen to this Podcast

Artwork for Pharmaceutical Executive

Latest Episodes

FDA grants accelerated approval to INOVIO’s Voceryq to reduce surgical burden in recurrent respiratory papillomatosis, Brox.AI’s Hamish Brocklebank on the three levels of digital clone use cases in pharma, and CytoDyn’s Dr. Jay Lalezari on his path f... more

In this episode of the Pharmaceutical Executive podcast, Scott LaGanga, executive vice president of state advocacy at PhRMA, discusses the expanding influence of state policymaking on drug pricing, pharmacy benefit manager reform, and efforts to tran... more

Bristol Myers Squibb discloses a patient death in its Phase I CAR-T multiple sclerosis trial, Pathos AI launches multi-year collaborations with Bristol Myers Squibb and Tempus AI to advance Alzheimer’s drug development, and health economist Dr. Nadin... more

Pharmaceutical and health economist Dr. Nadine Zawadzki, Senior Director, FTI Consulting joins the Ron Lanton Report to discuss how value is defined and measured across healthcare.

Key Facts

Accepts Guests
Contact Information
Podcast Host
Number of Listeners
Find out how many people listen to this podcast per episode and each month.

Similar Podcasts

People also subscribe to these shows.

Recent Guests

Nadine Zawadzki
Pharmaceutical and health economist and Senior Director at FTI Consulting
FTI Consulting
Episode: The Ron Lanton Report: A Conversation with Dr. Nadine Zawadzki
Dave Maraldo
Executive vice president and president of the Merck Manufacturing Division
Merck
Episode: Building Biopharma Manufacturing for Speed, Scale, and Flexibility
Jeffrey Sanzenbacher
Professor of the Practice of Economics at Boston College
Boston College
Episode: Pharmaceutical Executive Daily: Thomas Appio Named Interim CEO of Bausch + Lomb
Mark Talens
Chief Commercial Officer of PAXAFE
PAXAFE
Episode: Pharmaceutical Executive Daily: Thomas Appio Named Interim CEO of Bausch + Lomb
Adrian Gottschalk
Chief Executive Officer, Foghorn Therapeutics
Foghorn Therapeutics
Episode: Pharmaceutical Executive Daily: Foghorn Therapeutics & Eli Lilly Discontinue Development of FHD-909
Bo Liang
Chief Medical Officer, Corxel
Corxel
Episode: Pharmaceutical Executive Daily: Foghorn Therapeutics & Eli Lilly Discontinue Development of FHD-909
Michael Abrams
Managing partner at Numerov and Associates
Numerov and Associates
Episode: Pharmaceutical Executive Daily: FDA Approves Expanded Indication for Camzyos
Jeremy Levin
Co-founder and executive chairman of Ovid Therapeutics; veteran biopharmaceutical leader
Ovid Therapeutics
Episode: A Leadership Call to Action for Biotech
Ron Lanton
Attorney at Lanton-Lanton & Sosa Law
Lanton-Lanton & Sosa Law
Episode: Pharmaceutical Executive Daily: FDA Approves Welireg Plus Lenvima

Reviews

4.2 out of 5 stars from 31 ratings
  • A must listen

    A value-packed podcast in a tidy package! Every episode brings excellent perspectives from knowledgeable guests, with actionable leadership tips as the cherry on top. Don't miss it!

    Apple Podcasts
    5
    Arlie K
    United States6 years ago
  • Suggestion

    Hi! I really enjoy this podcast. You discuss great topics and interview knowledgeable people. Improving the sound quality would really make the listening experience much more enjoyable. There tends to be a muffled and unclear effect to the sound. Thanks!

    Apple Podcasts
    4
    pharmalova
    United States7 years ago

Listeners Say

Key themes from listener reviews, highlighting what works and what could be improved about the show.

Thoughtful leadership perspectives and actionable takeaways for executives.
High-quality guests with industry expertise and practical insights.
Some feedback notes sound quality could be improved for clearer listening.

Chart Rankings

How this podcast ranks in the Apple Podcasts, Spotify and YouTube charts.

Talking Points

Recent interactions between the hosts and their guests.

Building Biopharma Manufacturing for Speed, Scale, and Flexibility
Q: What capabilities from the next generation of manufacturing employees will be most important?
Maraldo identifies critical thinking and decision-making as essential amid growing data volumes, alongside digital fluency. He favors employees who combine engineering and scientific fundamentals with digital and automation skills.
Building Biopharma Manufacturing for Speed, Scale, and Flexibility
Q: What portfolio considerations or priorities are driving those investments, those decisions, those ramp ups? And how do you make long-term capacity decisions when clinical outcomes and future demand, it's uncertain.
Maraldo says Merck weighs pipeline risk and whether a technology is core to future products. It makes flexible internal investments in persistent capabilities such as antibody-drug conjugates, while using strategic partners to cover specialized or variable capacity needs.
The Ron Lanton Report: A Conversation with Dr. Nadine Zawadzki
Q: Has value-based care delivered what policymakers hoped that it would, or has it created another layer of complexity?
Zawadzki says value-based care has produced modest savings for Medicare, but tracking and reporting requirements create substantial administrative costs for providers. She says the effects on patient outcomes are not yet clear and argues that implementation should proceed gradually.
The Ron Lanton Report: A Conversation with Dr. Nadine Zawadzki
Q: When people talk about value in health care, what do they most often misunderstand?
Zawadzki says value is not synonymous with being cheap. It means assessing whether the quality or benefits justify the cost, while recognizing that patients may value choice and that different parties make decisions about what is worth paying for.
340B Under Pressure: Inside Pharma's Push for Greater Clarity
Q: How do you see litigation shaping the 340B conversation going forward?
Litigation is likely to continue, with courts shaping what data manufacturers can require and what contract restrictions are permissible, while a settlement or broader guidance could calm tensions if pilots succeed.

Audience Metrics

Listeners, social reach, demographics and more for this podcast.

Listeners per Episode
Gender Skew
Location
Interests
Professions
Age Range
Household Income
Social Media Reach

Frequently Asked Questions About Pharmaceutical Executive

What is Pharmaceutical Executive about and what kind of topics does it cover?

A leadership-focused series that centers on biotech, pharma, and life sciences leadership, with episodes covering strategic pivots, regulatory and policy shifts, and the economics of drug development and commercialization. Expect insights on AI in clinical trials and patient recruitment, dealmaking and financing, market access, and leadership governance. Notable is the emphasis on practical, real-world implications for executives, including how companies navigate policy uncertainty, funding shifts, and competitive dynamics while advancing therapies and patient access.

Where can I find podcast stats for Pharmaceutical Executive?

Rephonic provides a wide range of podcast stats for Pharmaceutical Executive. We scanned the web and collated all of the information that we could find in our comprehensive podcast database. See how many people listen to Pharmaceutical Executive and access YouTube viewership numbers, download stats, audience demographics, chart rankings, ratings, reviews and more.

How many listeners does Pharmaceutical Executive get?

Rephonic provides a full set of podcast information for four million podcasts, including the number of listeners. View further listenership figures for Pharmaceutical Executive, including podcast download numbers and subscriber numbers, so you can make better decisions about which podcasts to sponsor or be a guest on. You will need to upgrade your account to access this premium data.

What are the audience demographics for Pharmaceutical Executive?

Rephonic provides comprehensive predictive audience data for Pharmaceutical Executive, including gender skew, age, country, political leaning, income, professions, education level, and interests. You can access these listener demographics by upgrading your account.

How many subscribers and views does Pharmaceutical Executive have?

To see how many followers or subscribers Pharmaceutical Executive has on Spotify and other platforms such as Castbox and Podcast Addict, simply upgrade your account. You'll also find viewership figures for their YouTube channel if they have one.

Which podcasts are similar to Pharmaceutical Executive?

These podcasts share a similar audience with Pharmaceutical Executive:

1. BioCentury This Week
2. The Long Run with Luke Timmerman
3. The Readout Loud
4. Bloomberg Intelligence
5. Bloomberg Surveillance

How many episodes of Pharmaceutical Executive are there?

Pharmaceutical Executive launched 9 years ago and published 477 episodes to date. You can find more information about this podcast including rankings, audience demographics and engagement in our podcast database.

How do I contact Pharmaceutical Executive?

Our systems regularly scour the web to find email addresses and social media links for this podcast. We scanned the web and collated all of the contact information that we could find in our podcast database. But in the unlikely event that you can't find what you're looking for, our concierge service lets you request our research team to source better contacts for you.

Where can I see ratings and reviews for Pharmaceutical Executive?

Rephonic pulls ratings and reviews for Pharmaceutical Executive from multiple sources, including Spotify, Apple Podcasts, Castbox, and Podcast Addict.

View all the reviews in one place instead of visiting each platform individually and use this information to decide if a show is worth pitching or not.

How do I access podcast episode transcripts for Pharmaceutical Executive?

Rephonic provides full transcripts for episodes of Pharmaceutical Executive. Search within each transcript for your keywords, whether they be topics, brands or people, and figure out if it's worth pitching as a guest or sponsor. You can even set-up alerts to get notified when your keywords are mentioned.

What guests have appeared on Pharmaceutical Executive?

Recent guests on Pharmaceutical Executive include:

1. Nadine Zawadzki
2. Dave Maraldo
3. Jeffrey Sanzenbacher
4. Mark Talens
5. Adrian Gottschalk
6. Bo Liang
7. Michael Abrams
8. Jeremy Levin

To view more recent guests and their details, simply upgrade your Rephonic account. You'll also get access to a typical guest profile to help you decide if the show is worth pitching.

Find and pitch the right podcasts

We help savvy brands, marketers and PR professionals to find the right podcasts for any topic or niche. Get the data and contacts you need to pitch podcasts at scale and turn listeners into customers.
Try it free for 7 days